Microsoft's Bill Gates awards $9m grant to Cambridge firm seeking HIV cure

« Back to Industry News

10/01/2017

Bill Gates is pumping $9m into a Cambridge life sciences firm to strengthen its work developing novel treatments and vaccines for infectious diseases including HIV.

The Gates Foundation will provide Kymab with the research and development grant funding over the next three years to enable the firm to continue using its Kymouse antibody platform to come up with new therapies. The company has been working with the foundation, set up by the Microsoft tycoon and his wife, Melinda, since 2014, and this new grant cements their partnership.

Dr David Chiswell, CEO of Kymab, said: “We are delighted that the Bill & Melinda Gates Foundation has extended our collaboration. We have built a strong infectious disease programme under Professor Paul Kellam, our Vice-President of Vaccines & Infectious Disease, and we share the foundation’s aims to tackle diseases that have significant impact in some of the world’s poorest countries.

"We look forward to continuing to use our ability to produce human antibodies using our Kymouse technology to support and accelerate vaccine and therapeutic antibody development for global diseases.”


Click here to view the full related article.

« Back to Industry News